Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Spectrum

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Spectrum
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
Departments

Type 2 Diabetes Management in Primary Care: The Role of Retrospective, Professional Continuous Glucose Monitoring

  1. Maneesh Shrivastav1,
  2. William Gibson Jr.2,
  3. Rajendra Shrivastav3,
  4. Katie Elzea4,
  5. Cyrus Khambatta5,
  6. Rohan Sonawane1,
  7. Joseph A. Sierra1 and
  8. Robert Vigersky1
  1. 1Medtronic, Northridge, CA
  2. 2Diabetes Assessment and Management Center, Shreveport, LA
  3. 3Community Hospital of Staunton, Staunton, IL
  4. 4HealthEast Diabetes and Endocrinology, St. Paul, MN
  5. 5Mangoman Nutrition and Fitness, LLC, San Francisco, CA
  1. Corresponding author: Maneesh Shrivastav, maneesh.a.shrivastav{at}medtronic.com
Diabetes Spectrum 2018 Aug; 31(3): 279-287. https://doi.org/10.2337/ds17-0024
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Case 1 P-CGM reports: A) initial overlay, B) breakfast overlay, and C) P-CGM overlay ∼18 months after initial evaluation (February 2017).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Case 2 P-CGM reports: A) initial P-CGM overlay (October 2014) and B) post-DiAMC program P-CGM overlay (February 2015).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Case 3 P-CGM reports: A) initial P-CGM overlay (October 2014) and B) 30-day follow-up P-CGM overlay (November 2014).

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Case 4 P-CGM reports: A) initial P-CGM overlay (October 2016) and B) recent P-CGM report (February 2017).

Tables

  • Figures
  • TABLE 1.

    Comparison of P-CGM Systems by Manufacturer (7,8)

    Medtronic iPro2 P-CGMDexcom G4 PlatinumAbbott FreeStyle Libre Pro
    Duration of use (days)6714
    Insertion siteAbdomenAbdomenUpper arm
    Number of components2 (sensor and recorder)3 (transmitter, sensor, and receiver)2 (sensor and reader)
    Minimum number of calibrations per day220
    Reading frequency (min)5515
    Operational temperature (°F)36–8636–7750–86
  • TABLE 2.

    Reasons for P-CGM Use in Primary Care

    • Mitigation of hypoglycemia unawareness
    • Mitigation of nocturnal hypoglycemia unawareness
    • Provision of insight into nocturnal blood glucose patterns
    • Initiation of basal insulin (when necessary)
    • Understanding of when to initiate mealtime (prandial) insulin
    • Aid in adjusting the insulin-to-carbohydrate ratio for people with insulin-dependent diabetes
    • Understanding of how food affects blood glucose (i.e., how meals with various macronutrient ratios affect blood glucose profiles over the course of 24 hours)
    • Understand of how high-fat foods increase blood glucose over the course of 4–24 hours after ingestion
    • Increased patient accountability, which in turn improves patient self-care behaviors
    • Evaluation of the magnitude of the dawn phenomenon (i.e., early morning increase in blood glucose) and how it changes over time with lifestyle intervention
    • Reduction of medication and insulin use as patient’s insulin resistance or sensitivity changes
  • TABLE 3.

    Two-Visit P-CGM Workflow for PCP Clinic

    Visit 1: P-CGM InitiationVisit 2: P-CGM Report Review
    1. Discuss CGM basics with the patient.
    2. Set up and deploy P-CGM device on patient.
    3.Describe requirements for calibrating the device using a blood glucose meter.
    4. Reinforce the need for log-keeping (food, medication, and activity) and provide a log sheet or explain how to use a mobile app log (patient’s choice).
    5. Schedule a return visit to maximize device utility (typically 7–14 days of P-CGM wear, depending on the specific device’s approved duration of use).
    1. Remove the sensor from the P-CGM recorder and download data.
    2. Set preferences for individual target values and generate reports.
    3. Interpret reports and provide recommendations to the patient.
    4. Inform the patient about the effects of food, activity, and medications on blood glucose levels.
    5. Provide the patient with a take-home copy of reports as an educational tool.
  • TABLE 4.

    Work Breakdown for CGM CPT Codes

    CodeWorkflowMay Be Performed by:*Face-to-Face Meeting Required?
    95250: CGM placement, training, downloading, and report generationSensor insertionPhysician, nurse practitioner, or physician’s assistant or licensed staff within scope of practice or under direct supervision of providerYes
    Patient trainingYes
    Meter instructionYes
    Removal of transmitterYes
    Downloading of dataNo
    Entering blood glucose readingsNo
    Generating printed reportsNo
    95251: interpretation of CGM dataProvider analysis of reportsPhysician, nurse practitioner, or physician’s assistantNo
    • ↵* Staff may provide services if they meet the Medicare “incident to” rules for reimbursement of services rendered incident to a physician’s professional services.

PreviousNext
Back to top
Diabetes Spectrum: 31 (3)

In this Issue

August 2018, 31(3)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Spectrum.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Type 2 Diabetes Management in Primary Care: The Role of Retrospective, Professional Continuous Glucose Monitoring
(Your Name) has forwarded a page to you from Diabetes Spectrum
(Your Name) thought you would like to see this page from the Diabetes Spectrum web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Type 2 Diabetes Management in Primary Care: The Role of Retrospective, Professional Continuous Glucose Monitoring
Maneesh Shrivastav, William Gibson, Rajendra Shrivastav, Katie Elzea, Cyrus Khambatta, Rohan Sonawane, Joseph A. Sierra, Robert Vigersky
Diabetes Spectrum Aug 2018, 31 (3) 279-287; DOI: 10.2337/ds17-0024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Type 2 Diabetes Management in Primary Care: The Role of Retrospective, Professional Continuous Glucose Monitoring
Maneesh Shrivastav, William Gibson, Rajendra Shrivastav, Katie Elzea, Cyrus Khambatta, Rohan Sonawane, Joseph A. Sierra, Robert Vigersky
Diabetes Spectrum Aug 2018, 31 (3) 279-287; DOI: 10.2337/ds17-0024
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Crucial Role of Primary Care in Diabetes Management
    • Benefit of CGM
    • Commercially Available CGM Devices
    • P-CGM Reports
    • Recommendations for P-CGM
    • P-CGM Case Studies
    • Integration of P-CGM Into Primary Care
    • Cost and Reimbursement for P-CGM
    • Conclusion
    • Duality of Interest
    • Author Contributions
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
  • Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
  • Mental Health and Behavioral Screening in Pediatric Type 1 Diabetes
Show more Departments

Pharmacy and Therapeutics

  • Safety and Efficacy of Dietary Supplements for Diabetes
  • Injection-Site Nodules Associated With Once-Weekly Subcutaneous Administration of Semaglutide
  • Cannabidiol (CBD) Use in Type 2 Diabetes: A Case Report
Show more Pharmacy and Therapeutics

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Clinical Diabetes
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Spectrum Print ISSN: 1040-9165, Online ISSN: 1944-7353.